[HTML][HTML] Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

EA Meyerowitz, AGL Vannier, MGN Friesen… - The FASEB …, 2020 - ncbi.nlm.nih.gov
There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐
19). Early anecdotal reports and limited in vitro data led to the significant uptake of …

Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review

WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock… - Jama, 2020 - jamanetwork.com
Importance The coronavirus disease 2019 (COVID-19) pandemic, due to the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden …

Clinical management of COVID-19

GM Varghese, R John, A Manesh… - Indian Journal of …, 2020 - journals.lww.com
The novel coronavirus disease 2019 (COVID-19) with its early origin from Wuhan city in
China has evolved into a global pandemic. Maximal precautionary measures and resources …

Identification and diagnosis of long COVID-19: a scoping review

S Srikanth, JR Boulos, T Dover, L Boccuto… - Progress in biophysics …, 2023 - Elsevier
Abstract Long COVID-19 (LC-19) is a condition that has affected a high percentage of the
population that recovered from the initial disease caused by severe acute respiratory …

A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for …

CR Triggle, D Bansal, H Ding, MM Islam… - Frontiers in …, 2021 - frontiersin.org
COVID-19 emerged from China in December 2019 and during 2020 spread to every
continent including Antarctica. The coronavirus, SARS-CoV-2, has been identified as the …

The rise and fall of chloroquine/hydroxychloroquine as compassionate therapy of COVID-19

E Manivannan, C Karthikeyan… - Frontiers in …, 2021 - frontiersin.org
The emergence and rapid spread of novel coronavirus disease (COVID-19) has posed a
serious challenge to global public health in 2020. The speed of this viral spread together …

Millennium pandemic: a review of coronavirus disease (COVID-19)

S Bilgin, O Kurtkulagi… - Experimental …, 2020 - experimentalbiomedicalresearch …
Coronaviruses, a large family of single-stranded RNA viruses, can infect humans and
animals, and can cause neurological, gastrointestinal and hepatic diseases as well as …

COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations

B Zhou, S Kojima, A Kawamoto… - Journal of medical …, 2021 - Wiley Online Library
The pandemic of novel coronavirus disease (COVID‐19) is not yet close to being over, more
than 8 months after the first cases, but researchers are making great progress in fighting the …

[PDF][PDF] SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.

C Chakraborty, AR Sharma, G Sharma… - European Review for …, 2020 - europeanreview.org
SARS-CoV-2 is responsible for the outbreak of severe respiratory illness (COVID-19) in
Wuhan City, China and is now spreading rapidly throughout the world. The prompt outbreak …

[HTML][HTML] COVID-19: review of epidemiology and potential treatments against 2019 novel coronavirus

H Jan, S Faisal, A Khan, S Khan, H Usman, R Liaqat… - Discoveries, 2020 - ncbi.nlm.nih.gov
An epidemic of extreme respiratory deterrence, pneumonia and shortness of breath, the
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …